- CODEN : IAJPBB
- issn 2349-7750
TITLE:
AN OBSERVATIONAL STUDY ON THE ORAL ACYCLOVIR IN TREATING CHILDREN WITH VARICELLA INFECTION
AUTHORS:
Dr Sohaib Salam, Dr Iqra Akbar, Dr Sanan Akbar
ABSTRACT:
Objectives: The purpose of this research is to find the affect and difficulties rose by the disease which is spread by herpes varicella zoster virus in the sufferers who are purged from this disease with the help of an oral antiviral drug. Methodology: The method of this research is based on the observations. This research was carried out in Allied / DHQ Hospital Faisalabad and the duration of this study was from September 2019 to March 2020. All the patients aged from 2 to 15-years age whose medical reports confirmed the presence of the virus were treated from this oral antiviral drug. The quantity of the dose was 80 milligrams per kilogram per day for consecutive 5 days according to the weight of the patients. After this medical treatment, patients were thoroughly checked for complications and sufferings. The unfavourable effects and the economic value of this treatment were also evaluated in this research. Results: The total number of the affected children was 25 who participated in this research. 12 were the male participants and remaining 13 were the females. Temperature lasted from 1 to 8 days after this medical dealing. 56% sufferers were found with a medium skin complains. More than 19% sufferers had harsh skin complains and 20% persons were found with a low itchiness. The new skin complains appeared from 3 to 9 days. Other complications were appeared in only three participants in the result of the side effects of the drug. The economic cost of this medical treatment was more than three thousand rupees. Conclusion: the use of the antiviral drug against chicken pox hinders the new phase of the skin itching and the length of the period of disease to less than five days. Further studies are required to evaluate its advantages in relation with economic costs. KEYWORDS: Itching, Virus, Zoster, Herpes, Chicken Pox, Economic Cost, Antiviral
FULL TEXT
<Approved Journal
NLM ID:101711216 [Serial]
Included in EuroPub database
ICV 2015 - 61.16
Indexed In
S.J Impact Factor:7.157
cosmos Impact Factor:4.153
ICMJE Recommendations
IP Indexing Impact Factor: 2.76
Cover Page
